ECI Biotech is Awarded MA Workforce Training Fund Express Grant
Published: Jan 24, 2011
The Workforce Training Fund Express (WTF Express) offers matching grants to Massachusetts’ employers to train current and newly hired employees. The program is targeted to small employers with a maximum of 50 employees and to labor organizations.
The mission of the WTF Express is to provide organizations with the resources to invest in the Massachusetts workforce and improve employee skills, and to maintain the economic strength and viability of the Commonwealth's businesses.
Dr. Mitchell Sanders, the CEO and Founder of ECI Biotech, said, “ECI Biotech is thrilled to receive a WTF Express Grant Award. ECI’s path to commercialization starts in 2011 and the ISO certifications are required to support the near term diagnostic product launches in the US and Europe. The WTF Express grant will enable ECI employees to be trained for ISO compliance. We are indebted to the Massachusetts Manufacturing Extension Partnership (MassMEP) for providing our ISO QMS training and the ISO accreditations are one more step in the path to establishing global quality systems for manufacturing our diagnostic sensors in Worcester MA.”
ECI Biotech has a broad bacterial detection capability that has implications in the diagnosis and treatment of rapid infections. Our infection sensor diagnostics can be incorporated into any medical device or consumer product and will ultimately transform the way pathogens are detected in wound care, women's health, baby care and oral care.
“MassMEP is pleased to see companies, such as ECI Biotech, secure their ISO accreditation and grow our manufacturing base in Massachusetts.” ISO accreditation provides the necessary structure for Quality Management that is recognized in the Global Marketplace and is vital accreditation for today’s manufacturers.“ commented Jack Healy, Director of Operations, MassMEP.
About ECI Biotech
Founded in 1998, ECI Biotech is a developer of affordable diagnostic sensors trademarked as ExpressDetect®. ECI has developed technology targeted at prognosing chronic and acute wound infections that include a dressing sensor and a rapid point of care diagnostic. ECI has corporate partnerships in the areas of wound care, oral care, orthopedics, surgical and infection control. If you’re interested in partnering with ECI, visit www.ecibiotech.com